Bluebird Bio (BLUE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bluebird Bio (BLUE – Research Report), ...

Fulgent Genetics is transforming into a healthcare company with a focus on oncology, presenting a promising opportunity. Read ...

This has historically been a high-growth offering, and while it still targets such high-flying companies, it now includes a broader set of stocks. After a rough 2022, manager Paul Greene made a ...

More young people are ditching college for the workforce than ever before. If energized, they could play a major role in the ...

Progressive is a top performer in insurance, with impressive returns, strong financials, and growth potential, making it a ...

Gene therapy company Bluebird Bio on Tuesday announced a 25% reduction of its workforce as part of a restructuring.

The athleticwear company's latest use of AI allows it to use Google's Imagen tool to create photorealistic backgrounds for ...

Researchers have not only found a dream switch but may have figured out how to flip it, potentially transforming sleep medicine as we know it.

An advantage of stocks under $10 is that some of these stocks can make a good choice for short and medium-term trading strategies. Buying shares of a lower dollar amount also limits your exposure ...

the strange appearance in the background of a blurry figure in a blue dress who looks towards the camera, and indeed the ...

Innovative Industrial Properties Inc. 9% Cum. Conv. Redeem. Pfd. Series A 0.08% Digital Realty Trust Inc. 5.25% Cum. Conv. Pfd. Series J 0.37% Digital Realty Trust Inc. 5.2% Cum. Redeem. Pfd ...